Welcome
Respiratory syncytial virus (RSV) can lead to life-threatening respiratory infections in vulnerable populations including young infants, the elderly and immunocompromised adults. Discover:
- The burden of RSV in high-risk populations
- Unmet needs in RSV and RSV diagnosis
- Strategies for RSV prevention and treatment
Are you aware that respiratory syncytial virus (RSV) infection can lead to severe outcomes including death in high-risk populations? The unmet needs in RSV infection management are wide ranging. There is a need for improved diagnosis, particularly in vulnerable adult populations, RSV prevention strategies and RSV-targeting treatments.
With preventative RSV vaccines and RSV treatments currently under investigation, improved awareness of patients who are at risk of severe RSV infection will be key for integration of new strategies into clinical practice
In this RSV Learning Zone, find out more on risk factors for severe RSV infection, RSV burden, RSV diagnosis, as well as current and future RSV prevention and treatment strategies.
RSV burden
Risk factors for severe RSV infection
Diagnosing RSV
Unmet needs in RSV diagnosis and diagnostic strategies
Managing RSV
Preventative and treatment strategies for RSV
Accredited eLearning in Respiratory Syncytial Virus (RSV)
Discover our EACCME®-accredited eLearning module on addressing the unmet needs for respiratory syncytial virus (RSV) management in adults.
Congress Highlights
ERS, WONCA and ECCMID 2022 congress highlights
This content has been developed independently by EPG Health for Medthority and supported by an educational grant from Janssen in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
of interest
are looking at
saved
next event